Fig. 6From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinomaIn vivo anti-tumor activity: a tumor volume, b tumor weights, c body weights changes, d photographs of tumors and e TUNEL staining of tumor-bearing Balb/c-nu mice after treated with various formulations (n = 5; **p < 0.01; *p < 0.05)Back to article page